MENU
+Compare
CLRB
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$0.40
Change
+$0.12 (+42.86%)
Capitalization
18.4M

CLRB Cellectar Biosciences Forecast, Technical & Fundamental Analysis

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLRB with price predictions
Jun 04, 2025

CLRB in +76.15% Uptrend, growing for three consecutive days on June 04, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CLRB advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where CLRB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on CLRB as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CLRB just turned positive on May 19, 2025. Looking at past instances where CLRB's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

CLRB moved above its 50-day moving average on June 04, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLRB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CLRB broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CLRB entered a downward trend on May 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.379) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). CLRB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (265.014).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLRB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLRB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLRB is expected to report earnings to fall 224.27% to -13 cents per share on August 18

Cellectar Biosciences CLRB Stock Earnings Reports
Q2'25
Est.
$-0.14
Q1'25
Beat
by $0.30
Q4'24
Beat
by $0.28
Q3'24
Missed
by $0.07
Q2'24
Missed
by $0.02
The last earnings report on May 13 showed earnings per share of 10 cents, beating the estimate of -18 cents. With 39.51M shares outstanding, the current market capitalization sits at 18.40M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Campus Drive
Phone
+1 608 441-8120
Employees
20
Web
https://www.cellectar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RVSN0.390.01
+2.34%
Rail Vision Ltd
CYTK32.410.41
+1.28%
Cytokinetics
ASTE39.74-0.11
-0.28%
Astec Industries
BCML26.41-0.12
-0.43%
BayCom Corp
MTB179.87-2.74
-1.50%
M&T Bank Corp

CLRB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been closely correlated with QTTB. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
+66.32%
QTTB - CLRB
76%
Closely correlated
+0.52%
ANAB - CLRB
45%
Loosely correlated
-9.57%
ADCT - CLRB
44%
Loosely correlated
-6.96%
IBRX - CLRB
42%
Loosely correlated
+8.12%
CELC - CLRB
37%
Loosely correlated
+0.34%
More

Groups containing CLRB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
+66.32%
CLRB
(2 stocks)
78%
Closely correlated
+19.57%